The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
9 pts

Opinion on  EXACT Sciences Corp. (EXAS)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
BioMed Stock Movers: DNDN, EXAS, KG

Apr 08, 2009 03:36 PM GMT
Mikerun
Return Risk
+1.04% LOW
Principal

Dendreon (DNDN) has stalled out around $6.50 per share after a major rally on news of upcoming presentation at a medical conference later this month. DNDN expects to report Provenge clinical trial results some time before the end of April, although it did not guarantee this would occur at the upcoming presentation.

The recent spike in shares of DNDN and upcoming presentation do not provide any clarity on whether Provenge results will be sufficient for attaining FDA approval and the pending data release will determine the Company's fate.

http://biomedreports.com/articles/most-popular/767-fda-calend...

King Pharma (KG) on Goldman's conviction buy list with $10 price target

Check out my article at

http://biomedreports.com/articles/most-popular/683-king-pharm...

EXACT Sciences (EXAS) moving up steadily since briefly moving below a dollar late last week. EXAS trading on light volumes this week, but moving to the upside with last trade at $1.19 today. Below is a link to my two latest articles on EXAS:

http://biomedreports.com/articles/latest-news/678-exact-scien...

Disclosure: I own shares of EXAS.


EXAS:  This call was made on 04/08/09 @ $1.19
Rating:   Positive   $1.19 (04/08/09)
Closed:   04/09/2009 @ $1.1 (-7.56% in 20 hours)


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.56% 370
2 Gerald Greene 18.14 +69.43% 207
3 stockmarketfunding.com 17.66 +25.71% 53
4 akiralegrand 13.47 +14.32% 61
5 anup2104 12.13 +75.75% 34


POPULAR STOCKS
Symbol Company Name Sentiment
FNM Fannie Mae
WM Washington Mutual Inc
FSLR First Solar Inc.
AMZN Amazoncom Inc
AMD Advanced Micro Devices Inc
F Ford Motor Company

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
EXACT Sciences Corp. (EXAS)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
100.0%
Top:
100.0%




Latest Picks by Mike Havrilla
Symbol SP Sentiment Rating Return Since
IMUC N/A Positive n/a 11/09/09
EXAS Positive +1.52% 11/07/09
NFES N/A Positive n/a 11/07/09
ESALY N/A Negative n/a 11/04/09
PFE Negative -2.95% 11/04/09

View All >
   
Mike Havrilla previously rated EXAS
Positive +1.52% EXACT Sciences (NASDAQ: EXAS): Buy and Hold for Long-Term Upside
11/07/2009
9
Positive +6.48% EXACT Sciences (NASDAQ: EXAS): Patience Required for Long-Term Upside
11/03/2009
9
Positive -0.81% BioMed News Bytes: Rockwell Medical, EXACT Sciences, MannKind
10/29/2009
9
Positive -9.45% BioMed News Bytes: Cytori, EXACT Sciences, HEPI
10/03/2009
9
Positive -6.46% Rodman Conference Recaps: EXACT Sciences, Delcath, Unilife
09/13/2009
9
Positive +13.51% EXACT Sciences: Smaller Phase 3 Study Will Save Time, Money
08/14/2009
9
Positive -8.16% New Indexes to Track Healthcare Trends and More
08/04/2009
9
Positive +1.44% EXACT Sciences: FDA-Cleared Test Key to Future Earnings
08/01/2009
9
Positive +1.46% EXACT Sciences (NASDAQ:EXAS): Back on Track, Report Available
07/15/2009
9
Positive +158.49% New Index of Cancer Diagnostic and Therapeutic Stocks
04/12/2009
9
Positive -3.64% BioMedReports.com Most Popular Links
04/09/2009
9
Positive +19.00% EXACT Sciences Announces New Management Team
03/18/2009
1
Positive -40.83% EXACT Sciences Forms Pact with Genzyme
01/28/2009
9
Positive +14.18% Healthcare Hot Spots Beyond Stem Cells
01/26/2009
9
Positive -0.66% New Preventive Medicine Index
01/25/2009
9
Positive +7.97% Create Your Own Diagnostics ETF
01/20/2009
9
Positive -8.00% EXACT Sciences Rejects Sequenom's $41M Offer
01/12/2009
9
Positive +0.00% EXACT
01/12/2009
9
Positive -0.66% Analyzing Sequenom's Offer for EXACT Sciences
01/12/2009
9
Positive +8.63% Buyout Binge Begins for Bio-Pharma, Diagnostics
01/10/2009
1
Positive +152.73% A New Emerging Diagnostics Index
12/26/2008
1
Positive -35.29% EXACT Sciences Next Generation Stool-Based DNA Technology Outperforms Blood Plasma Testing
08/08/2008
3
Positive +19.70% ColoSure & Cost Reductions Key to EXACT's Future
07/19/2008
3





IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch